231 related articles for article (PubMed ID: 22147321)
1. An unusual cause of retention of urine after intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer.
Cheung JM; Hou SS; Yip SK; Ng CF
Hong Kong Med J; 2011 Dec; 17(6):492-4. PubMed ID: 22147321
[TBL] [Abstract][Full Text] [Related]
2. Perianal abscess as a complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer.
Köksal AS; Bilge Z; Torun S; Saşmaz N; Yazicioğlu AH
Acta Gastroenterol Belg; 2013 Jun; 76(2):260. PubMed ID: 23898568
[No Abstract] [Full Text] [Related]
3. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
4. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
5. [Systemic BCG reactions after intravesical BCG therapy. A report of four cases].
Sfaxi M; Langar H; Ouni A; Riahi Y; El Aidli S; Daghfous R; Ben Abdeladhim A; Chébil M
Therapie; 2008; 63(1):43-7. PubMed ID: 18387275
[TBL] [Abstract][Full Text] [Related]
6. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
[TBL] [Abstract][Full Text] [Related]
7. Prostatorectal fistula following intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the urinary bladder.
Enatsu N; Ota T; Ochi A
Int J Urol; 2010 Sep; 17(9):822-3. PubMed ID: 20727055
[No Abstract] [Full Text] [Related]
8. Strategies for optimizing bacillus Calmette-Guérin.
Shah JB; Kamat AM
Urol Clin North Am; 2013 May; 40(2):211-8. PubMed ID: 23540779
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
Ozbakkaloglu B; Tünger O; Sürücüoglu S; Lekili M; Kandiloglu AR
Int Urol Nephrol; 1999; 31(1):49-53. PubMed ID: 10408303
[TBL] [Abstract][Full Text] [Related]
10. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
Misra S; Gupta A; Symes A; Duncan J
Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
[TBL] [Abstract][Full Text] [Related]
11. Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.
Lestre SI; Gameiro CD; João A; Lopes MJ
An Bras Dermatol; 2011; 86(4):759-62. PubMed ID: 21987145
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
[TBL] [Abstract][Full Text] [Related]
13. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.
Iantorno R; Nicolai M; Storto ML; Ciccotosto C; Cipollone G; Mastroprimiano G; Tenaglia RL
J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372
[No Abstract] [Full Text] [Related]
14. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.
Robinson ARL; Radhakrishnan R; Horvath R; Pandey S
Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313
[TBL] [Abstract][Full Text] [Related]
15. Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
Yokomizo A; Kanimoto Y; Okamura T; Ozono S; Koga H; Iwamura M; Tanaka H; Takahashi S; Tsushima T; Kanayama HO; Akaza H; Shinohara N; Mugiya S; Nomata K; Nakamura T; Naito S
J Urol; 2016 Jan; 195(1):41-6. PubMed ID: 26307162
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
17. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
Manasia P; Alcaraz A; Cetina A; Alcover J
J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
[No Abstract] [Full Text] [Related]
18. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.
Marques M; Vazquez D; Sousa S; Mesquita G; Duarte M; Ferreira R
Pulmonology; 2020; 26(6):346-352. PubMed ID: 31711964
[TBL] [Abstract][Full Text] [Related]
20. An unexpected complication of bacillus Calmette-Guérin therapy.
Yildiz H; Colin G; Lambert M
Acta Clin Belg; 2014 Aug; 69(4):312. PubMed ID: 24846180
[No Abstract] [Full Text] [Related]
[Next] [New Search]